Anticancer Activity of Triazolo-Thiadiazole Derivatives and Inhibition of AKT1 and AKT2 Activation
The fusion of 1,2,4-triazole and 1,3,4-thiadiazole rings results in a class of heterocycles compounds with an extensive range of pharmacological properties. A series of 1,2,4-triazolo[3,4-<i>b</i>]-1,2,4-thiadiazoles was synthesized and tested for its enzyme inhibition potential and anti...
Wedi'i Gadw mewn:
Prif Awduron: | Dimitrios T. Trafalis (Awdur), Sofia Sagredou (Awdur), Panayiotis Dalezis (Awdur), Maria Voura (Awdur), Stella Fountoulaki (Awdur), Nikolaos Nikoleousakos (Awdur), Konstantinos Almpanakis (Awdur), Maria V. Deligiorgi (Awdur), Vasiliki Sarli (Awdur) |
---|---|
Fformat: | Llyfr |
Cyhoeddwyd: |
MDPI AG,
2021-04-01T00:00:00Z.
|
Pynciau: | |
Mynediad Ar-lein: | Connect to this object online. |
Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|
Eitemau Tebyg
-
Effects of a Novel Thiadiazole Derivative with High Anticancer Activity on Cancer Cell Immunogenic Markers: Mismatch Repair System, PD-L1 Expression, and Tumor Mutation Burden
gan: Sofia Sagredou, et al.
Cyhoeddwyd: (2021) -
Synthesis and biological activity of bisindole derivatives as novel MARK4 inhibitors
gan: Maria Voura, et al.
Cyhoeddwyd: (2022) -
8-Hydroxy-2'-Deoxyguanosine and 8-Nitroguanine Production and Detection in Blood Serum of Breast Cancer Patients in Response to Postoperative Complementary External Ionizing Irradiation of Normal Tissues
gan: Kosmas E. Verigos, et al.
Cyhoeddwyd: (2020) -
Triazolo Based-Thiadiazole Derivatives. Synthesis, Biological Evaluation and Molecular Docking Studies
gan: Charalampos Kamoutsis, et al.
Cyhoeddwyd: (2021) -
Sesuvium Portulacastrum Potentiates Anticancer Activity by Facilitating the Expression of IRS-1/AKT Signalling: An In vitro Study
gan: Mukundh S Tarun, et al.
Cyhoeddwyd: (2024)